Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

China flag China · Delayed Price · Currency is CNY
4.890
+0.050 (1.03%)
Mar 10, 2026, 2:04 PM CST
-30.83%
Market Cap 3.16B
Revenue (ttm) 246.35M
Net Income (ttm) 171.34M
Shares Out 651.90M
EPS (ttm) 0.27
PE Ratio 18.25
Forward PE n/a
Dividend 0.08 (1.61%)
Ex-Dividend Date Jul 15, 2025
Volume 8,369,700
Average Volume 25,153,168
Open 4.850
Previous Close 4.840
Day's Range 4.850 - 4.920
52-Week Range 4.590 - 8.010
Beta 0.50
RSI 34.05
Earnings Date Apr 30, 2026

About SHA:603718

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloprot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 366
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603718
Full Company Profile

Financial Performance

In 2024, SHA:603718's revenue was 271.04 million, an increase of 12.59% compared to the previous year's 240.72 million. Earnings were 171.18 million, an increase of 172.28%.

Financial Statements

News

There is no news available yet.